Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine
DP Momesso, F Vaisman, SP Yang… - The Journal of …, 2016 - academic.oup.com
Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …
stratification in patients with differentiated thyroid cancer (DTC) treated with total …
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
DP Momesso, F Vaisman, SP Yang… - The Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Context Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …
stratification in patients with differentiated thyroid cancer (DTC) treated with total …
DYNAMIC RISK STRATIFICATION IN DIFFERENTIATED THYROID CANCER PATIENTS TREATED WITHOUT RADIOACTIVE IODINE
DP Momesso, F Vaisman, SP Yang… - Journal of Clinical …, 2016 - hero.epa.gov
CONTEXT: While response to therapy assessment is a validated tool for dynamic risk
stratification in differentiated thyroid cancer (DTC) patients treated with total thyroidectomy …
stratification in differentiated thyroid cancer (DTC) patients treated with total thyroidectomy …
[HTML][HTML] Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
DP Momesso, F Vaisman, SP Yang… - The Journal of …, 2016 - ncbi.nlm.nih.gov
Objective: This study aimed to validate the response to therapy assessment in patients with
DTC treated with lobectomy or TT without RAI. Design and Setting: This was a retrospective …
DTC treated with lobectomy or TT without RAI. Design and Setting: This was a retrospective …
[PDF][PDF] DYNAMIC RISK STRATIFICATION IN DIFFERENTIATED THYROID CANCER PATIENTS TREATED WITHOUT RADIOACTIVE IODINE
DP Momesso, F Vaisman, SP Yang, DA Bulzico… - 2016 - researchgate.net
Objectives: To validate the response to therapy assessment in DTC patients treated with L or
TT without RAI. Design: Retrospective study, median follow-up period of 100.5 months …
TT without RAI. Design: Retrospective study, median follow-up period of 100.5 months …
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.
DP Momesso, F Vaisman, SP Yang… - The Journal of …, 2016 - europepmc.org
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without
Radioactive Iodine. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
Radioactive Iodine. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.
DP Momesso, F Vaisman, SP Yang… - The Journal of …, 2016 - europepmc.org
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without
Radioactive Iodine. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
Radioactive Iodine. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …